Therapeutic effects of PG201, an ethanol extract from herbs, through cartilage protection on collagenase-induced arthritis in rabbits

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 1469-1477

  Park, Kyoung Chul ^a   Park, Eun Jin ^c   Kim, Eun Ran ^a   Kim, Yeonran ^a   Chung, Suk Hee ^a   Cho, Byoung Wook ^b   Kim, Sunyoung ^a,c   Jin, Mirim ^a  

^a Seoul National University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c ChumSeongDae Oriental Medicine Clin   (South Korea)

Author keywords

Cartilage protection; Collagenase induced arthritis; Herbal medicine; Inflammatory mediators; MMPs; Osteoarthritis; PG201; Proteoglycan; TIMP 2

Indexed keywords

COLLAGENASE; COLLAGENASE 3; DICLOFENAC; HERBACEOUS AGENT; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; NITRIC OXIDE; PG 201; PROSTAGLANDIN E2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; HERB; INFLAMMATION; JOINT STIFFNESS; KNEE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BASE SEQUENCE; CARTILAGE, ARTICULAR; COLLAGENASES; DNA PRIMERS; INFLAMMATION MEDIATORS; MEDICINE, HERBAL; PLANT EXTRACTS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ORYCTOLAGUS CUNICULUS;

EID: 18844451754     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.030     Document Type: Article

References (40)

1. A.R. Poole An introduction to the pathophysiology of osteoarthritis Front. Biosci. 4 1999 662 670
2. P. Dieppe, J.A. Chard, A. Faulkner, and S. Lohmander Osteoarthritis Bartons Clinical evidence 2000 BMJ Publishing Group London 649 663
3. A.R. Poole Cartilage in health and disease 14th ed. W.J. Koopman Arthritis and allied conditions: a textbook of rheumatology 2000 Lippincott Williams & Wilkins Philadelphia 226 284
4. J.F. Woessner Matrix metalloproteinase and their inhibitors in connective tissue remodeling FASEB J. 5 1991 2145 2154
5. N. Isiguro, T. Ito, H. Iwata, H. Jugessur, M. Ionescu, and A.R. Poole Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis Arthritis Rheum. 42 1999 129 136
6. D.D. Dean, J. Martel-Pelletier, J.-P. Pelletier, D.S. Howell, and J.F. Woessner Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage J. Clin. Invest. 84 1989 678 685
7. J.T. Dingle, B.P. Thomas, and K.D.R. Bard In vivo studies of articular tissue damage mediated by catabolin/interleukin-1 Ann. Rheum. Dis. 50 1991 75 80
8. M.B. Goldring, J.R. Birkdale, R. Suen, S. Yamin, J. Misuno, and J.L. Glowacki Interleukin 1beta modified gene expression in immortalized human chondrocytes J. Clin. Invest. 94 1994 2307 2316
9. J. Martel-Pelletier, N. Alaaeddine, and J.-P. Pelletier Cytokines and their role in the pathophysiology of osteoarthritis Front. Biosci. 4 1999 694 703
10. S. Marini, G.F. Fasciglione, G. Monteleone, M. Maiotti, U. Tarantino, and M. Coletta A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinase activities Clin. Biochem. 36 2003 295 304
11. J. Martel-Pellettier, R. McCollum, N. Fujimoto, K. Obata, J.M. Cloutier, and J.P. Pelletier Excess of metalloproteinase over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis Lab. Invest. 70 1994 807 815
12. C.J. Jackson, J. Arkell, and M. Nguyen Rheumatoid synovial endothelial cells secret decreased levels of tissue inhibitors of MMP Ann. Rheum. Dis. 57 1998 158 161
13. S. Laufers Osteoarthritis therapy-are there still unmet needs Rheumatology 43 Suppl. 2004 i9 i15
14. P. Creamer Osteoarthritis pain and treatment Curr. Opin. Rheumatol. 12 2000 450 455
15. S.S. Shin, M. Jin, H.J. Jung, B. Kim, H. Jeon, and J.J. Choi Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice Rheumatology 42 2003 665 672
16. T. Kikuchi, T. Sakuta, and T. Yamaguchi Intra-articular injection of collagenase experimental osteoarthritis in mature rabbits Osteoarthritis Cartilage 6 1998 177 186
17. Y.M. Meidany, M. Maafary, and I. Ahmed Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in rheumatoid arthritis patients Joint Bone Spine 70 2003 195 202
18. E.I. Chiang, P.J. Bagley, J. Selhub, M. Nadeau, and R. Roubenoff Abnormal Vitamin B6 Satus is associated with severity of symptoms in patients with rheumatoid arthritis Am. J. Med. 114 2003 283 287
19. H. Shiozaki, Y. Koga, G. Omori, G. Yamamoto, and H.E. Takahashi Epidemiology of osteoarthritis of the knee in a rural Japanese population Knee 6 1999 183 188
20. J.M. Kim, S.H. Ho, and E.J. Park Angiogenesis gene transfer as an effective treatment strategy in murine collagen-induced arthritis Arthritis Rheum. 46 2002 793 801
21. G.E. Kempson, H. Muir, C. Pollard, and M. Tuke The tensile properties of the cartilage of human femoral condoyle related to the content of collagen and glycosaminoglycans Biochim. Biophys. Acta 297 1973 456 472
22. P.J. Roushley, and E.R. Lee Cartilage proteoglycans: structure and potential functions Microsc. Res. Tech. 28 1994 385 397
23. K. Messener, J. Gillquist, S. Bjornsson, and S.L. Lohmander Proteoglycan fragments in rabbit joint fluid correlated to arthrosis stage Acta Orthop. Scand. 64 1993 312 316
24. C. Belcher, R. Yaqub, F. Fawthrop, M. Bayless, and M. Doherty Synovial fluid chondroitin and keratin sulfate epitopes, glycosaminoglycans and hyaluronan in arthritic and normal knees Ann. Rheum. Dis. 56 1997 299 307
25. A. Legrand, B. Fermer, C. Fink, D.S. Pistetsky, J.B. Weinberg, and T.P. Vail Interleukin-1, tumor necrosis factor-α, IL-17 synergically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci Arthritis Rheum. 44 2001 2078 2083
26. M.M. Hardy, K. Seibert, P.T. Manning, M.G. Currie, B.M. Woerner, and D. Edwards Cyclooxygenase2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants Arthritis Rheum. 46 2002 1789 1803
27. M.A. Cake, R.A. Read, R.C. Appleyard, S.Y. Hwa, and P. Ghosh The nitric oxide donor glyceryl trinitrate increase subchondral bone sclerosis and cartilage degeneration following ovine menisectomy Osteoarthritis Cartilage 12 2004 974 981
28. K. Brandt, G.N. Smith Jr., and L.S. Simon Intra-articular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum. 43 2000 1192 1203
29. L.S Lohmander, N. Dalen, G. Englund, M. Hamalainen, E.M. Jensen, and K. Karsson Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized, double blind, placebo-controlled multi-center trial Ann. Rheum. Dis. 55 1996 424 431
30. C.J. Meininger, K.A. Kelly, H. Li, T.E. Haynes, and G. Wu Glucosamine inhibits inducible nitric oxide synthesis Biochem. Biophys. Res. Commun. 279 2000 234 239
31. T.E. McAlindon, M.P. LaValley, J.P. Gulin, and D. Felson Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis JAMA 283 2000 1469 1475
32. S.Y. Chang, and C.W. Howden Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal disease Curr. Gastroenterol. Rep. 6 2004 447 453
33. M. Mamdani, D.N. Juurlink, A. Kopp, G. Nalglie, P.C. Austin, and A. Laupacis Gastrointestinal bleeding after the introduction of COX-2 inhibitors: ecological study BMJ 328 2004 1415 1416
34. L. Akhud, R.J. Quinet, and S. Ishag Celecoxib-related renal papillary necrosis Arch. Intern. Med. 163 2003 114 115
35. T. Ishikawa, F. Nishigaki, S. Miyata, Y. Hirayona, K. Minoura, and J. Imanishi Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor FR 255031 Br. J. Pharmacol. 144 2005 133 143
36. N. Renggli-Zulliger, J. Dudler, N. Fujimoto, K. Iwata, and S.O. Alexander Use of encapsulated cells secreting murine TIMP-2 ameliorates collagen-induced arthritis in mice Ann. NY Acad. Sci. 878 1999 515 518
37. M.Y. Celiker, N. Ramamurthy, J.W. Xu, M. Wang, Y. Jiang, R. Greenwarld, and Y.E. Shi Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinase 4 gene delivery Arthritis Rheum. 46 2002 3361 3368
38. S. Lacraz, L.P. Nicod, R. Chicheportiche, H.G. Welgus, and J. Dayer IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes J. Clin. Invest. 96 1995 2304 2310
39. H. Ihn, K. Yamane, Y. Asano, M. Kubo, and K. Tamaki IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway J. Immunol. 168 2002 1895 1902
40. S. Ho, W. Han, H. Lee, D. Kim, J. Jeong, and S. Kim Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4 Biochem. Biophys. Res. Commun. 321 2004 756 766